Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Hypertension Reviews
  4. Volume 20, Issue 3
  5. Article
Volume 20, Issue 3
  • ISSN: 1573-4021
  • E-ISSN: 1875-6506

Abstract

Introduction

The role of Angiotensin-converting enzyme (ACE and ACE2) phenotypes and polymorphisms in modulating severe acute respiratory syndrome coronavirus (SARSCoV-2) infection in hypertensive patients remains unclear. Our objective was to determine the distribution of ACE and ACE2 receptor phenotypes by patient demographics and correlate ACE and ACE2 levels of activity with SARS-CoV-2 outcomes.

Methods

Hypertensive patients treated for SARS-CoV-2 at an urban emergency department (ED) were prospectively enrolled in a cohort study between August 2020 and April 2021. Blood samples were collected during ED visits or hospitalization. Outcome measures including hospitalization, intensive care unit (ICU) admission, and 30-day mortality were obtained from electronic health records. Multivariable logistic regression was used.

Results

Of the 150 patients enrolled, 60% were Black, 32% Hispanic/Latinx, 4% Non-Hispanic Whites, and 4% others. The mean age was 59 (+/-14) years. The rate of hospitalization was high (86%) and Hispanic/Latinx had a higher likelihood of ICU admission. Patients harboring the rs2285666 genotype TT, AA, and GC alleles were more likely to be admitted to ICU, and those with TT and AA had higher mortality. The ACE level was a significant predictor of hospitalization with a protective effect in both unadjusted and adjusted results. Hispanics/Latinx had a four times higher likelihood of ICU admission compared to all others, and age was significantly associated with 30-day mortality.

Conclusion

Our results show that even after adjusting for age, race, and sex, ACE levels remained a predictor of hospitalization. ACE/ACE2 phenotypes and genotypes potentially play an important role in disease progression in SARS-CoV-2 patients.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chyr/10.2174/0115734021315730240919062555
2024-10-15
2025-03-07

  • From This Site

    /content/journals/chyr/10.2174/0115734021315730240919062555
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SugS. FryarC.D. CarrollM.D. Hypertension Prevalence and Control Among Adults: United States, 2011-2014.NCHS Data Brief201522018
     [Google Scholar]
  2. High Blood Pressure Facts.2024Available from: https://www.cdc.gov/high-blood-pressure/data-research/facts-stats/index.html
  3. AggarwalR. ChiuN. WadheraR.K. MoranA.E. RaberI. ShenC. YehR.W. KaziD.S. Racial/ethnic disparities in hypertension prevalence, awareness, treatment, and control in the United States, 2013 to 2018.Hypertension20217861719172610.1161/HYPERTENSIONAHA.121.1757034365809
     [Google Scholar]
  4. AlcendorD.J. Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US.J. Clin. Med.202098244210.3390/jcm908244232751633
     [Google Scholar]
  5. TaiD.B.G. ShahA. DoubeniC.A. SiaI.G. WielandM.L. The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States.Clin. Infect. Dis.202172470370610.1093/cid/ciaa81532562416
     [Google Scholar]
  6. Latest Data.Available from: https://www.chicago.gov/city/en/sites/covid-19/home/covid-dashboard.html
  7. SolerM.J. BarriosC. OlivaR. BatlleD. Pharmacologic modulation of ACE2 expression.Curr. Hypertens. Rep.200810541041410.1007/s11906‑008‑0076‑018775121
     [Google Scholar]
  8. ShahH. KhanM.S.H. DhurandharN.V. HegdeV. The triumvirate: Why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.Acta Diabetol.202158783184310.1007/s00592‑020‑01636‑z33587177
     [Google Scholar]
  9. BossoM. ThanarajT.A. Abu-FarhaM. AlanbaeiM. AbubakerJ. Al-MullaF. The two faces of ACE2: the role of ACE2 receptor and its polymorphisms in hypertension and COVID-19.Mol. Ther. Methods Clin. Dev.20201832132710.1016/j.omtm.2020.06.01732665962
     [Google Scholar]
  10. LiuY. YangY. ZhangC. HuangF. WangF. YuanJ. WangZ. LiJ. LiJ. FengC. ZhangZ. WangL. PengL. ChenL. QinY. ZhaoD. TanS. YinL. XuJ. ZhouC. JiangC. LiuL. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.Sci. China Life Sci.202063336437410.1007/s11427‑020‑1643‑832048163
     [Google Scholar]
  11. SuzukiY. Ruiz-OrtegaM. LorenzoO. RuperezM. EstebanV. EgidoJ. Inflammation and angiotensin II.Int. J. Biochem. Cell Biol.200335688190010.1016/S1357‑2725(02)00271‑612676174
     [Google Scholar]
  12. ImaiY. KubaK. PenningerJ.M. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice.Exp. Physiol.200893554354810.1113/expphysiol.2007.04004818448662
     [Google Scholar]
  13. WuZ. HuR. ZhangC. RenW. YuA. ZhouX. Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients.Crit. Care202024129010.1186/s13054‑020‑03015‑032503680
     [Google Scholar]
  14. MitchellP.D. BuckleyC. SubramaniamA. CrowtherS. DonnellyS.C. Elevated serum ACE levels in patients with post-acute COVID-19 syndrome.QJM20221151065165210.1093/qjmed/hcac11935588264
     [Google Scholar]
  15. GuJ. KortewegC. Pathology and pathogenesis of severe acute respiratory syndrome.Am. J. Pathol.200717041136114710.2353/ajpath.2007.06108817392154
     [Google Scholar]
  16. ZhaoY. ZhaoZ. WangY. ZhouY. MaY. ZuoW. Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.Am. J. Respir. Crit. Care Med.2020202575675910.1164/rccm.202001‑0179LE32663409
     [Google Scholar]
  17. SinghU. WurteleE.S. Differential expression of COVID-19-related genes in European Americans and African Americans.bioRxiv2020.06.09.14327110.1101/2020.06.09.143271
     [Google Scholar]
  18. RigatB. HubertC. Alhenc-GelasF. CambienF. CorvolP. SoubrierF. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.J. Clin. Invest.19908641343134610.1172/JCI1148441976655
     [Google Scholar]
  19. RigatB. HubertC. CorvolP. SoubrierR. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).Nucleic Acids Res.19922061433143310.1093/nar/20.6.1433‑a1313972
     [Google Scholar]
  20. HanC. HanX.K. LiuF.C. HuangJ.F. Ethnic differences in the association between angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral vascular disease: A meta-analysis.Chronic Dis. Transl. Med.20173423024110.1016/j.cdtm.2017.07.00229354806
     [Google Scholar]
  21. SarangarajanR. WinnR. KiebishM.A. BountraC. GrangerE. NarainN.R. Ethnic prevalence of angiotensin-converting enzyme deletion (D) polymorphism and COVID-19 risk: Rationale for use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers.J. Racial Ethn. Health Disparities20218497398010.1007/s40615‑020‑00853‑032901433
     [Google Scholar]
  22. KeikhaM. KarbalaeiM. Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis.Microb. Pathog.202217210578110.1016/j.micpath.2022.10578136116608
     [Google Scholar]
  23. Avanoglu GulerA. TombulN. Aysert YıldızP. ÖzgerH.S. HızelK. GulbaharO. TufanA. ErbaşG. AygencelG. Guzel TunçcanO. DizbayM. ÖztürkM.A. The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease.Scand. J. Clin. Lab. Invest.202181216016510.1080/00365513.2021.187164133474994
     [Google Scholar]
  24. ZhuZ. CaiT. FanL. LouK. HuaX. HuangZ. GaoG. The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019.BMC Infect. Dis.202020188310.1186/s12879‑020‑05619‑x33238910
     [Google Scholar]
  25. GhanbariH. DehghaniA. FeiziA. AmirkhaniA. PouraziziM. Serum level of the angiotensin-converting enzyme in patients with idiopathic acute optic neuritis: A case-control study.Scientifica (Cairo)202020201510.1155/2020/486742032318310
     [Google Scholar]
  26. KahkoueeS. SamadiK. AlaiA. AbediniA. RezaiianL. Serum ACE level in sarcoidosis patients with typical and atypical HRCT manifestation.Pol. Przegl. Radiol. Med. Nukl.20168145846110.12659/PJR.89770827733890
     [Google Scholar]
  27. RiceG.I. JonesA.L. GrantP.J. CarterA.M. TurnerA.J. HooperN.M. Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study.Hypertension200648591492010.1161/01.HYP.0000244543.91937.7917000927
     [Google Scholar]
  28. PanM. VasbinderA. AndersonE. CatalanT. ShadidH.R. BerlinH. PadaliaK. O’HayerP. MelocheC. AzamT.U. KhaleelI. MichaudE. BlakelyP. BitarA. HuangY. ZhaoL. Pop-BusuiR. LoosenS.H. ChalkiasA. TackeF. Giamarellos-BourboulisE.J. ReiserJ. Eugen-OlsenJ. HayekS.S. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and outcomes in patients hospitalized for COVID-19.J. Am. Heart Assoc.20211024e02353510.1161/JAHA.121.02353534889102
     [Google Scholar]
  29. MolnarM.Z. Kalantar-ZadehK. LottE.H. LuJ.L. MalakauskasS.M. MaJ.Z. QuarlesD.L. KovesdyC.P. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.J. Am. Coll. Cardiol.201463765065810.1016/j.jacc.2013.10.05024269363
     [Google Scholar]
  30. FliserD. BuchholzK. HallerH. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation.Circulation200411091103110710.1161/01.CIR.0000140265.21608.8E15313950
     [Google Scholar]
/content/journals/chyr/10.2174/0115734021315730240919062555
Loading
Association of Angiotensin Converting Enzyme Phenotypes and Polymorphisms with Clinical Outcomes in SARS-CoV2 Patients with Hypertension in an Urban Emergency Department
Current Hypertension Reviews 20, 166 (2024); https://doi.org/10.2174/0115734021315730240919062555
/content/journals/chyr/10.2174/0115734021315730240919062555
/content/journals/chyr/10.2174/0115734021315730240919062555
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): ACE; ACE2; angiotensin-converting enzyme; COVID-19; hospitalization; hypertension

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test